Literature DB >> 18432419

Dose-response features of neuroprotective agents: an integrative summary.

Edward J Calabrese1.   

Abstract

This article provides an integrative summary of the effects of neuroprotective agents on neuronal survival and neurite outgrowth using primary cell cultures, multiple neuronal cell lines, and astroglial cells. These findings are dealt with in considerable detail in the following three articles (Calabrese, 2008a, 2008b, 2008c) of this series of issues of Critical Reviews in Toxicology. The principal finding is that the overwhelming majority of neuroprotective agents display biphasic dose responses, characterized by modest low-dose enhancement/stimulation and high-dose inhibitory responses. The quantitative features of these dose responses are consistent with the hormetic dose-response model. Mechanisms that account for numerous hormetic dose responses of neuroprotective agents are summarized, as well as the clinical implications of specific experimental findings.

Mesh:

Substances:

Year:  2008        PMID: 18432419     DOI: 10.1080/10408440801981965

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  10 in total

1.  Hormesis pervasiveness and its potential implications for pharmaceutical research and development.

Authors:  Kenneth I Maynard
Journal:  Dose Response       Date:  2011-07-29       Impact factor: 2.658

2.  A perspective on the scientific, philosophical, and policy dimensions of hormesis.

Authors:  George R Hoffmann
Journal:  Dose Response       Date:  2009-01-19       Impact factor: 2.658

3.  FK962 induces neurite outgrowth in cultured monkey trigeminal ganglion cells.

Authors:  Emi Nakajima; Ryan D Walkup; Thomas R Shearer; Mitsuyoshi Azuma
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-24       Impact factor: 3.117

Review 4.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

5.  Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gamma.

Authors:  Wensheng Lin; Phillip E Kunkler; Heather P Harding; David Ron; Richard P Kraig; Brian Popko
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 6.  Hormesis and Female Sex Hormones.

Authors:  Jakob O Strom; Annette Theodorsson; Elvar Theodorsson
Journal:  Pharmaceuticals (Basel)       Date:  2011-05-16

7.  Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways.

Authors:  Chao Zhang; Chuwen Li; Shenghui Chen; Zhiping Li; Xuejing Jia; Kai Wang; Jiaolin Bao; Yeer Liang; Xiaotong Wang; Meiwan Chen; Peng Li; Huanxing Su; Jian-Bo Wan; Simon Ming Yuen Lee; Kechun Liu; Chengwei He
Journal:  Redox Biol       Date:  2016-11-04       Impact factor: 11.799

8.  Hormetic effect of panaxatriol saponins confers neuroprotection in PC12 cells and zebrafish through PI3K/AKT/mTOR and AMPK/SIRT1/FOXO3 pathways.

Authors:  Chao Zhang; Chuwen Li; Shenghui Chen; Zhiping Li; Lijuan Ma; Xuejing Jia; Kai Wang; Jiaolin Bao; Yeer Liang; Meiwan Chen; Peng Li; Huanxing Su; Simon Ming Yuen Lee; Kechun Liu; Jian-Bo Wan; Chengwei He
Journal:  Sci Rep       Date:  2017-01-23       Impact factor: 4.379

Review 9.  The role of hormesis in the functional performance and protection of neural systems.

Authors:  Edward J Calabrese; Vittorio Calabrese; James Giordano
Journal:  Brain Circ       Date:  2017-03-29

Review 10.  PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease.

Authors:  Sanaz Keshavarz Shahbaz; Khadijeh Koushki; Thozhukat Sathyapalan; Muhammed Majeed; Amirhossein Sahebkar
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.